DEA Reschedules Hydrocodone Combination Products

Posted in Latest News on September 26, 2014.

On Friday, August 22nd, the U. S. Drug Enforcement Administration (DEA) published a Final Rule moving hydrocodone combination products (HCPs) from Schedule III to the more-restrictive Schedule II. This Final Rule imposes the regulatory controls and sanctions applicable to Schedule II substances on those who handle or propose to handle HCPs. The rule goes into effect 45 days from its publish date.

The entire rule text may be found here:  https://www.federalregister.gov/articles/2014/08/22/2014-19922/schedules-of-controlled-substances-rescheduling-of-hydrocodone-combination-products-from-schedule

Frequently Asked Questions regarding this change may be found here: Hydrocodone FAQs



More Latest News

Board Chairs/Vice Chairs Annual Long-range Planning Meeting
January 11, 2019

The Annual Long Range Planning meeting has been scheduled for Friday, May 31, 2019. Please click here for more information. Continue reading


A Tool to Report Health Care Provider Complaints
January 8, 2019

The Complaint Portal is a way for consumers to find the correct agency to submit health care complaints in an electronic and secure format. Continue reading